1.22
+0.06(+5.17%)
Currency In USD
| Previous Close | 1.16 |
| Open | 1.16 |
| Day High | 1.27 |
| Day Low | 1.16 |
| 52-Week High | 4.42 |
| 52-Week Low | 0.85 |
| Volume | 258,344 |
| Average Volume | 638,604 |
| Market Cap | 55.72M |
| PE | -1.18 |
| EPS | -1.03 |
| Moving Average 50 Days | 1.22 |
| Moving Average 200 Days | 2.24 |
| Change | 0.06 |
If you invested $1000 in PDS Biotechnology Corporation (PDSB) since IPO date, it would be worth $5.55 as of May 09, 2025 at a share price of $1.22. Whereas If you bought $1000 worth of PDS Biotechnology Corporation (PDSB) shares 5 years ago, it would be worth $1,292.37 as of May 09, 2025 at a share price of $1.22.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting
GlobeNewswire Inc.
Yesterday at 12:00 PM GMT
Infectimune® studies funded by and performed by investigators at the National Institute of Allergy and Infectious Diseases (NIAID)’s Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP)PRINCETON, N.J., May 08, 2025 (GLOBE NEWS
PDS Biotech Announces Conference Call and Webcast for First Quarter 2025 Financial Results
GlobeNewswire Inc.
May 07, 2025 12:00 PM GMT
PRINCETON, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today annou
PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire Inc.
Apr 23, 2025 2:16 PM GMT
PRINCETON, N.J., April 23, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ann